While processes are in place for severe adverse drug events, more subtle indicators of potential safety issues can be buried in disparate data silos.
Goals and Objectives
Being able to access all data across a trial (both current and completed) in real time can highlight early indicators of efficacy and/or potential drug safety issues. Once recognized, these issues can be built into automated workflows so all other trials (both current and future) benefit.
- Secure clouds
- Predictive analytics
- Automated workflows
Use Case Summary
The ability to analyze all trial data in real time provides a continuing opportunity to monitor for existing patient risk factors and identify new ones that can threaten patient safety.